SPHERA FUNDS MANAGEMENT LTD.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1496201
TEL AVIV, L3
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,220,510
-$4,028,227 QoQ
Shares Held
422,051
-51.3% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#66
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $61,616,864 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (6.8% of the industry book) .
All Filings in BCRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,220,510 | 422,051 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,248,737 | 866,464 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,535,534 | 837,889 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||